相关实验视频

Updated: Jan 12, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

在胰腺癌复发后意外完全缓解:综合多式疗法病例报告

Shangyou Zheng¹, Huimou Chen², Chonghui Hu¹

¹Department of Pancreas Center, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.

Frontiers in oncology

|November 3, 2025

概括

胰腺管道腺癌 (PDAC) 是一种具有侵略性的癌症. 手术切除之后的化疗提供了生存益处,早期发现复发对于管理这种具有挑战性的癌症至关重要.

科学领域:

胃肠病学胃肠病学
手术瘤学手术瘤学
医学瘤学医学瘤学

背景情况:

胰腺管道腺癌 (PDAC) 是一种高度侵袭性的胃肠道恶性瘤,预后不佳.
周围组织的早期透使诊断和治疗计划复杂化.
尽管采用多模式治疗方法,但复发率仍然很高.

研究的目的:

要呈现一个PDAC病例,最初被误诊为十二指肠恶性瘤.
突出外科切除和辅助化疗在切除的PDAC中的疗效.
强调术后监测的重要性和了解伪进展.

主要方法:

机器人辅助腹腔镜胰腺二切除术用于瘤切除.
用修改的AG (GN) 疗程进行辅助化疗.
随后使用纳利里福克斯治疗腹转移的治疗.

主要成果:

最终的病理学证实了中度差异化的PDAC.
17个月的无瘤存活期在术后通过辅助化疗实现.
在NALIRIFOX治疗复发性腹膜疾病后达到完全缓解.

结论:

手术干预和辅助化疗对于可切除的PDAC至关重要.
警的术后监测对于早期发现复发是必不可少的.
解释成像发现需要考虑PDAC管理中的伪进展.

关键词:

我们的PDAC是PDAC.化疗化疗是一种化学疗法.伪进步是一种伪进步.可切除的胰腺癌.瘤的复发瘤的复发

更多相关视频

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: